Search Results
You are looking at 1 - 3 of 3 items for
- Author: Gary Sweeney x
- Refine by access: All content x
Search for other papers by Rengasamy Palanivel in
Google Scholar
PubMed
Search for other papers by Vivian Vu in
Google Scholar
PubMed
Search for other papers by Min Park in
Google Scholar
PubMed
Search for other papers by Xiangping Fang in
Google Scholar
PubMed
Search for other papers by Gary Sweeney in
Google Scholar
PubMed
The causal relationship between obesity and cardiovascular disease is extensively acknowledged; however, the exact mechanisms linking obesity and heart failure remain unclear. Here, we investigated the influence of adipokines derived from primary adipocytes on glucose and fatty acid uptake and metabolism in isolated primary cardiomyocytes. Either co-culture of these cell types or incubation with adipocyte-conditioned medium significantly increased glucose uptake in cardiomyocytes. When streptozotocin-induced diabetic rats were used as a source of adipocytes, there was a lower ability to elicit glucose uptake in cardiomyocytes which corresponded with lower Akt and AMPK phosphorylation. The profile of glucose metabolism also differed with oxidation being favored upon co-culture with wild-type adipocytes whereas lactate production was strongly induced by adipocytes from diabetic rats. Examination of fatty acid uptake revealed that stimulation only occurred in response to adipokines secreted by wild-type rat adipocytes. Importantly, oxidation of fatty acids by cardiomyocytes was decreased by adipokines derived from diabetic rat adipocytes. Analysis of adipokine profiles in diabetic rat adipocyte-conditioned medium demonstrated the most significant decreases in adiponectin and leptin with increased IL6 expression. Taken together, these data suggest that the profile of adipokines secreted by adipocytes from diabetic rats have a deleterious influence on cardiomyocyte metabolism which may be of relevance in the pathophysiology of heart failure.
Search for other papers by Rengasamy Palanivel in
Google Scholar
PubMed
Search for other papers by Vivian Vu in
Google Scholar
PubMed
Search for other papers by Min Park in
Google Scholar
PubMed
Search for other papers by Xiangping Fang in
Google Scholar
PubMed
Search for other papers by Gary Sweeney in
Google Scholar
PubMed
Search for other papers by Thanh Q Dang in
Google Scholar
PubMed
Search for other papers by Nanyoung Yoon in
Google Scholar
PubMed
Search for other papers by Helen Chasiotis in
Google Scholar
PubMed
Search for other papers by Emily C Dunford in
Google Scholar
PubMed
Search for other papers by Qilong Feng in
Google Scholar
PubMed
Search for other papers by Pingnian He in
Google Scholar
PubMed
Search for other papers by Michael C Riddell in
Google Scholar
PubMed
Search for other papers by Scott P Kelly in
Google Scholar
PubMed
Search for other papers by Gary Sweeney in
Google Scholar
PubMed
Altered permeability of the endothelial barrier in a variety of tissues has implications both in disease pathogenesis and treatment. Glucocorticoids are potent mediators of endothelial permeability, and this forms the basis for their heavily prescribed use as medications to treat ocular disease. However, the effect of glucocorticoids on endothelial barriers elsewhere in the body is less well studied. Here, we investigated glucocorticoid-mediated changes in endothelial flux of Adiponectin (Ad), a hormone with a critical role in diabetes. First, we used monolayers of endothelial cells in vitro and found that the glucocorticoid dexamethasone increased transendothelial electrical resistance and reduced permeability of polyethylene glycol (PEG, molecular weight 4000 Da). Dexamethasone reduced flux of Ad from the apical to basolateral side, measured both by ELISA and Western blotting. We then examined a diabetic rat model induced by treatment with exogenous corticosterone, which was characterized by glucose intolerance and hyperinsulinemia. There was no change in circulating Ad but less Ad protein in skeletal muscle homogenates, despite slightly higher mRNA levels, in diabetic vs control muscles. Dexamethasone-induced changes in Ad flux across endothelial monolayers were associated with alterations in the abundance of select claudin tight junction (TJ) proteins. shRNA-mediated knockdown of one such gene, claudin-7, in HUVEC resulted in decreased TEER and increased adiponectin flux, confirming the functional significance of Dex-induced changes in its expression. In conclusion, our study identifies glucocorticoid-mediated reductions in flux of Ad across endothelial monolayers in vivo and in vitro. This suggests that impaired Ad action in target tissues, as a consequence of reduced transendothelial flux, may contribute to the glucocorticoid-induced diabetic phenotype.
